ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Cabaletta Bio at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

Cabaletta Bio brings 3 presentations to ACR Convergence 2026 in Orlando, and exhibits at Booth 4104. Its program centres on rese-cel, an engineered CAR T-cell therapy, covering its safety profile in refractory autoimmune disease, the RESET clinical program and a survey of preferences for CAR T-cell use in myositis.

OrganizationACR Convergence 2026 Attendance
Cabaletta Bio
Philadelphia, PA
Biotech companies
A clinical-stage biotechnology company developing engineered T-cell therapies for autoimmune diseases.
Booth
Exhibiting at Booth 4104
Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm
Poster
Mon Nov 9
10:30am–12:30pm
Industry
Tue Nov 10
1:30pm–2:15pm
Designed for Autoimmunity: Rese-cel and the RESET Clinical Program
Innovation Theater B
Immunology · with University of Michigan

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Cabaletta Bio

Tell us what you sell and we’ll find the people at Cabaletta Bio most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction